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ABSTRACT
Norepinephrine (NIC) and epinephrine (JO) uro metabolized extra** 
neuronally by cateehol-O-melhyl-trnnHfornHe to Liu; tnetanephrinos 
(JVINh), normotanephrine (NMN) and motnnophrino (MN), Subjects in 
this study received in(iihìoiih of tritium-labeled NIO and 10, Concen­
trations ofMNs and catecholamines won» measured in plasma flowing 
into and out of the heart, forearm, kidneys, mesenteric organs 
(gastrointestinal tract, spleen, and pancreas), liver, at\d adrenals to 
examine t'ho regional production ofMNs from circulating and locally 
released catecholamines. NIO spillover* from mesenteric organs and 
kidneys accounted (or (>4% of the spillover from all tissues. There was 
detectable spillover of 10 from most extraadrenal tissues, butHlW was 
from the adrenals. The production ofMNs irom locally released and 
circulating catecholamines varied widely among tissues. The liver 
made the lardosi contribution to removal of circulating NIO (57%) and
10 (¡Î2%) and the largest, contribution to the production ol'NMN (54%) 
and MN { from metabolism of circulating catecholamines. In al! 
other tissues more NMN was produced from locally released than 
from circulating NE. TIiuh, the metabolism of circulating NK wan 
responsible for only 19% of the i.iîtal production of NMN. An even 
Handler portion (0%) of plasma MN wan derived from metabolism of 
circulating 10. Mont plasma MN (91//Î) wan produced within the adre­
nals, which also provided the I argent single source (23%) of NMN, The 
regional variation in uxtraneuronal production ofM Ns indicates con­
siderable heterogeneity in how circulating and locally released cat­
echolamines uns handled by different tissues. The substantial con­
tribution of the adrenals to the production of MNs explains the 
extraordinary sensitivity of these metabolites for the diagnosis of 
pheochromocytoma. (J (-tin ICnrfucrinol Mvlab 80: U(H)Î)-ïl017, UWfi)
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ESTIMA'IION of norepinophrino (Nl!) spillover into the circulation, using the dilution of iv infused | l|[]NIi 
with endogenous NH in plasma (i.e. the specific activity of 
plasma I '11|NK) provides a useful index of NK release from 
sympathetic nerves (I). Most released NH, however, is effi­
ciently removed by neuronal and exlraneuronal uptake, so 
that only a small portion escapes into the circulation (2). 
Additional measurements of dihydroxyphenylglycol, the in­
traneuronal cleaminated metabolite of Nli, enable estimation 
of neuronal NK reuptake (3-5). The metanephrines (MNs), 
nonnetanephrine (NMN) and metanephrine (MN) are ex­
traneuronal ( )-methylated metabolites of NIi and epineph­
rine (10; thus, measurements of their plasma concentrations 
enable examination of the exlraneuronal uptake and metab­
olism of catecholamines (6, 7).
The above use of catecholamine metabolites to examine the 
neuronal and exlraneuronal disposition of catecholamines 
depends on measurements of specific activities of metabo­
lites and their precursor amines in plasma during the infu­
sion of '11-labeled catecholamines. In particular, differences 
in specific activities of Hi-labeled metabolites entering and 
leaving an organ are dependent on the relative amounts of
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metabolite derived from two sources: 1) metabolism of high 
specific activity catecholamine rem oved from in-flowing 
plasma, and 2) metabolism of locally released unlabeled 
catecholamine,
This study applied the above considerations to examine 
the sources of plasma MNs and assess w hether the extran­
euronal removal and metabolism of catecholamines vary *
among different tissues. Concentrations of MNs and cat­
echolamines were measured in plasma flowing into and out 
of the heart, forearm, lungs, kidneys, adrenals, mesenteric 
organs, and liver. Samples of plasma draining mesenteric 
organs were obtained from the portal vein and, thus, rep­
resent plasma drain ing  the gastrointestinal tract, spleen, and 
pancreas. Results in the intact innervated heart were com ­
pared with those in patients w ith heart transplants, Dener­
vation of cardiac sym pathetic nerves in these patients would 
be expected to produce little influence of locally released NK 
on the specific activity of [J l I]NMN leaving the heart.
S u b je c ts  a n d  M e th o d s
Subjects
Subjects were studied its pari of ongoing protocols at 1 different 
institutions: the Nil i ,  the University of Ciotemrg, and St. Radboud 
University Hospital. Regional blood sampling vvas carried out in 7
'  ‘  .................................................................................................................................................................................  I-
patient
ui i ivLMMi I iwrtjMuii i \ q ; i u i u u i u u u un u u n u u win ✓
subjects studied in a cardiac cat bet eri/a I ion laboratory, N patients stm 
ied during surgical anesthesia, and ID subjects studied in a i
/
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observation room. All procedures were approved by the appropriate 
review committees, and all subjects gave informed written consent to 
participate in studies.
Subjects examined in a cardiac catheterization laboratory included 7 
normal volunteers (6 males and 1 female; 29-39 yr old), 20 patients with 
angina pectoris with and without coronary artery disease (18 males and
2 females; 48-71 yr old), 39 patients with cardiac failure secondary to 
coronary artery disease or idiopathic dilated cardiomyopathy (30 males 
and 9 females; 33-75 yr old), 8 patients who had received heart trans­
plants '1 yr previously (7 males and 1 female; 28-64 yr old), 2 male 
patients with renal artery stenosis (55 and 62 yr old), and 1 male patient 
during inferior vena caval blood sampling for localization of a suspected 
pheochromocytoma (38 yr old). The latter patient was subsequently 
determined not to harbor a tumor. Patients with heart failure were 
receiving a variety of medications (typically some combination of cal­
cium channel blockers, digoxin, angiotensin-converting enzyme inhib­
itors, /3-blockers, nitrates, and diuretics) that were discontinued for 12 
h before the study. Patients with heart transplants were receiving cy- 
closporine, azathioprine, and prednisone, Al other subjects remained 
unmedicated for at least 48 h before the studies.
Patients studied during surgical anesthesia included five males and 
three females (47-77 yr old). The presence of a gastric adenocarcinoma 
provided the reason for surgery in seven patients, whereas a pancreatic 
neoplasm was the reason for surgery in the other patient. No signs of 
hepatic or distant metastases were found in any patient. Anesthesia was 
induced with sodium thiopental (3-5 m g/kg) and vecuronium bromide 
(1.5 mg/kg). Patients were intubated and mechanically ventilated with 
30% oxygen and 70% nitrous oxide. Anesthesia was maintained with 
enflurane (0.5-0.7 minimum alveolar anesthetic concentration), fentanyl 
(2.5-3.0 g/kg), and midazolam (1 m g/kg) as needed.
Subjects studied in a patient observation room included five normal 
volunteers and five patients with essential hypertension (six males and 
four females; 28-47 yr old). All subjects were studied in the supine 
position, did not receive any medication for 2 weeks before the study, 
and hnd abstained from nicotine, alcohol, and caffeinated beverages for 
at least 12 h before the study.
Infusions of tritium-labeled catecholamines
All subjects, except the suspected pheochromocytoma patient, re­
ceived infusions of PHINE (levo-2,5,6-pH]NE; 40-60 Ci/mmol; New  
England Nuclear Corp., Boston, MA) either delivered alone or, in most 
(65 of 95) cases, in combination with pH]E (levo-JST-/i/^ /^/iy/-[3H]E; 65-75 
Ci/mmol; also from New England Nuclear). The radiotracers were 
infused into a forearm vein at 1.0-1,5 jmCi/min.
Blood sampling and blood flow determinations
Blood samples (10 mL) were collected into prechilled syringes at least
15 min after the start of radiotracer infusions. For patients studied in 
catheterization laboratories, blood samples (10 mL) were taken simul­
taneously from a radial or femoral artery and from the coronary sinus 
(n = 62), the pulmonary artery (n — 36), or the right renal vein (n = 43). 
To examine MN production by the adrenals, blood samples were taken 
from an adrenal vein in four subjects and from the left and right renal 
veins in two subjects. In the latter subjects the catheter to the left kidney 
was advanced proximally to the vein draining the left adrenal so that the 
blood collected included effluent from both the left kidney and the left 
adrenal. Coronary sinus blood flow and cardiac output were determined 
by thermodilution, whereas renal blood flow was determined from the 
total body clearance and renal extraction of ^-aminohippurate.
For patients studied during surgical anesthesia, blood samples were 
taken simultaneously from a radial artery, the portal vein, and the right 
hepatic vein. Samples from the portal vein were taken by venipuncture, 
whereas those from the hepatic vein were taken using a catheter ad­
vanced to the site from a femoral vein. Blood flow through the hepatic 
artery and portal vein were measured using ultrasound transit time flow 
probes connected to a HT207 dual channel flowmeter (Transonic 
Systems, Ithaca, NY).
Studies carried out in a patient observation room involved simulta­
neous sampling of blood from a brachial artery and a deep antecubital 
vein. Forearm blood flow was measured using venous occlusion strain
gauge plethysmography with circulation to the hand excluded by in­
flation of a wrist cuff to 100 mm Hg above systolic pressure for the 
duration of each blood flow determination.
Blood samples were collected into ice-cold tubes containing an an­
ticoagulant [heparin, ethylenediamine tetraacetate, or ethyleneglycol- 
bis-(j3-aminoethyl eîher)-N,N,N' ,N '-tetrad ce tic acidl and stored on ice 
until studies were completed. Samples were then centrifuged at 4 C, and 
plasma was separated for storage at -8 0  C until assayed for plasma 
concentrations of catecholarnines and MNs.
Assays
The MNs (NMN and MN) were extracted from 2 mL plasma using 
solid phase ion exchange columns and quantified by liquid chroma­
tography with electrochemical detection (8). The catecholamines (NE 
and E) were extracted from 1-mL samples of plasma using alumina and 
quantified by liquid chromatography with electrochemical detection (9). 
Timed collections of eluants leaving the electrochemical cell, followed by 
liquid scintillation spectroscopy, enabled determination of plasma con­
centrations of 3H-labeled catecholamines and MNs. Interassay coeffi­
cients of variation were 12.2% for NMN, 11.2% for MN, 6.5% for NE, and
11.4% for E. Intraassay coefficients of variation were 4.2% for NMN, 3.3% 
for MN, 1.9% for NE, mid 3.0%; for E.
Calculations
The fraction of catecholamine in in-flowing plasma removed during 
passage through an organ (fxc) was estimated according to the equation 
fxc -  (p',H]CI -  pHlCoi/PHlQ (Eq I), where p.H]C, and PHIQ, are the 
respective in-flowing and out-flowing plasma concentrations of '^ H- 
labeled catecholamine (disintegrations per min/mL). Rates of removal 
(picomoles per min) of catecholamines by a specific organ or tissue were 
estimated from the product of fxc with the in-flowing plasma concen­
tration of catecholamine and the plasma flow through the organ.
The specific activity (SA) of an ^IT-labeled catecholamine precursor or 
O-methyl a ted amine metabolite in plasma (i.e. the concentration of tri­
tium bound to the amine divided by the concentration of the amine) was 
estimated according to the equation SA = [3H]A/A (Eq II), where PlI|A 
is the plasma concentration of the tritium bound to the amine (disin­
tegrations per min/mL), and A is the plasma concentration of the amine 
(picomoles per mL).
For a tissue with negligible local release of catecholamine the 
denervated transplanted heart or E in extraadrenal tissues), but which 
metabolizes circulating Yl-labeled and endogenous catecholamines to 
MNs, the specific activity of the ^H-labeled metabolite in out-flowing 
plasma (SA0) is dependent on the higher specific activity of the pHlcat- 
echolamine precursor (SAC) and the lower specific activity of the 'IT- 
labeled metabolite (SAT) in in-flowing plasma. Under the above condi­
tions, the proportion (pG) of metabolite in out-flowing plasma derived 
from metabolism of in-flowing catecholamine can be estimated accord­
ing to a previously described approach (10) using the equation 
pa -  (SA0 -  SAi)/(SAc; -  SA,) (Eq III).
Under the same conditions, the fraction of metabolite removed 
during passage through the organ (fxM) can then be estimated by 
correction of the out-flowing plasma concentration of endogenous 
metabolite for the contribution from in-flowing precursor according 
to the equation fxM = [M, -  (M0 -  pn X M0 )]/M, (Eq IV), where M, 
and Mn are the respective concentrations (picomoles per mL) of MN 
(or NMN in a denervated organ) in in-flowing and out-flowing 
plasma, and pQ is estimated from Eq 111. Rates of removal (picomoles 
per min) of MNs by specific tissues were estimated from the product 
of fxM with the in-flowing plasma concentration of metabolite and the 
plasma flow through the organ.
The spillover of endogenous catecholamine or NMN into plasma 
from an organ (S) was then estimated according to the equation (11) S 
~ F X  [(A0 -  A,) + (fx X A,)l (Eq V), where F is the plasma flow through 
the organ (milliliters per min), Aj and A0 are the respective in-flowing 
and out-flowing plasma amine concentrations (picomoles per mL), and 
fx is the fractional extraction of the amine (from Eq 1 and IV). For 
estimation of NMN spillover, the fractional extraction of NMN was 
assumed to equal the fractional extraction of MN,
The proportion of extracted NE or E metabolized to NMN or MN (pc)
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was estimated according to the equation pc -  [[3H]M0 — (pH]Mj X 
fxM)]/([3H]C1 X fxc) (Eq VI), where [3H]M, and pH]M0 are the respec­
tive concentrations of 3H-labeled MN or NMN in in-flowing and out­
flowing plasma, and the other terms are described in Eq I and IV above.
The spillover of NMN or MN derived from local metabolism of the 
NE or E extracted from in-flowing plasma by the organ or tissue (SP) was 
then estimated using the equation S,> = (pc X fxc X C,) X F (Eq VII); all 
terms are described in Eq I, IV, and VI above. The spillover of NMN 
derived from metabolism of locally released NE was then estimated by 
subtraction of SP from the total spillover of NMN.
Plasma flows in the forearm were measured in units of milliliters per 
100 mL tissue/miii, so that forearm spillovers have units of picomoles 
per 100 mL/min, Previously documented data about the density of 
skeletal muscle (12) and the mass of skeletal muscle in the body as a 
function of gender and body weight (13) were used to transform rates 
of catecholamine and MN spillover and removal for the forearm into 
rates for skeletal muscle throughout the body (units of picomoles per 
min). The above transformation assumes that spillovers from the fore­
arm reflect spillovers from skeletal muscle elsewhere in the body.
Rates of spillover of catecholamines and MNs from the adrenals were 
estimated using two methods. In the two patients from whom blood 
samples were obtained from the right renal vein and the common vein 
draining the left kidney and left adrenal gland, spillovers were estimated 
from the product of renal plasma flow and differences in catecholamine 
or MN concentrations at the two sampling sites. In the other patients 
from whom adrenal venous blood samples were obtained, adrenal sp­
illovers of catecholamines were estimated according to Eq V above. 
Adrenal spillovers of MNs were estimated similarly, except that no 
correction was made for fractional extractions, which were assumed to 
be negligible in relation to the arterial-venous increase in concentrations. 
Adrenal blood flow was assumed to equal 30 mL/min, as derived from 
previously documented data (14, 15).
StatisticaI methods
Results are expressed as means with variance for paired data (i.e. 
in-flowing and out-flowing plasma concentrations of MNs and frac­
tional extractions of NE and E) shown using sks of the difference and for 
other data using sum . Plasma concentrations of catecholamines and MNs 
are not normally distributed. Therefore, levels of statistical significance 
were determined using nonparametric methods; Wilcoxon's signed rank 
sum test was used for comparisons of paired data, and the Mann- 
Whitney test was used for comparisons of other data. Unless stated, 
statistical significance was defined as P < 0.05.
TABLE 1. Concentrations of metaneplrrines in plasma flowing 
into and out of various organs and tissues
0.001)
R esults
Regional dijfcrenc.es in plasma MNs
There wa s a 12 ± 2% arteria 1-venous increase (P < 
in plasma concentrations of NMN across the heart (Table 1). 
No other organ, apart from the adrenals, showed evidence of 
loca 1 production of NMN, as indicated by increases in NMN 
concentrations from in-flowing to out-flowing plasma. In 
contrast, concentrations of MN in in-flowing plasma were 
consistently higher (P <  0.01) than those in out-flowing 
plasma for every tissue, except the adrenals. The kidneys and 
liver showed the largest arterial-venous decreases (P <  0.005) 
in plasma MN. These organs also showed decreases (P <  
0.01) in in-flowing to out-flowing plasma concentrations of 
NMN, indicating local extraction of both NMN and MN. 
Local production of MNs was most evident for the adrenals, 
which showed a 10-fold arterial-venous increase in plasma 
NMN and an 87-fold increase in plasma MN.
Handling of MNs by the transplanted and innervated heart
No. Inflowing Outflowing SED
Heart
NMN 57 0.293 0.329 ±0.005"
MN 62 0.256 0.210 ±0.004'*
Forearm
NMN 10 0.260 0.299 ±0.024
MN 10 0.279 0.175 ±0.012*
Lungs
NMN 34 0.317 0.314 ±0,007
MN 36 0.260 0.244 ±0.006*
Kidneys
NMN 40 0,281 0.256 ±0.008
MN 41 0.246 0.154 ±0.007*
Mesenteric organs
NMN 7 0,399 0.380 ±0.024
MN 8 0.283 0.195 ±0.027'*
Liver
NMN 7 0.384 0.212 ±0.047
MN 7 0.243 0.090 ±0.034*
Adrenals
NMN 4 0.378 3.951 ±2.122
MN 4 0.274 23.857 ±16.362
Results represent mean plasma concentrations (picomoles per mL) 
with variance between inflowing and outflowing concentrations 
Bhown by the his of the difference (SED).
fi Significantly higher concentration in outflowing than inflowing 
plasma.
h Significantly lower concentration in outflowing than inflowing 
plasma,
fairly consistent, increases (P <  0 .002) in N M N  from arterial 
to coronary venous plasma, patients w ith heart transplants 
showed consistent arterial-coronary venous decreases (P < 
0.02) in plasma N M N  (Fig, 1, top panel). Plasma concentra­
tions of MN showed similar arterial-coronary venous de­
creases (P <  0.02) in bo th  innervated control subjects and 
denervated heart transplant patients (Fig. I, bottom panel). 
This and lack of a difference in arterial and  coronary venous 
concentrations of [3I-I]MN resulted in a highly consistent 20,2 
± 2.2% increase (P <  0.001 ) in the specific activity of pH IM N  
from arterial to coronary venous plasma.
In contrast to the increase in specific activity of [3H]MN 
across the heart, control subjects show ed a small, bu t con­
sistent, decrease (P <  0.001) in the specific activity of 
[nH]NMN from arterial to coronary venous plasma. On the 
other hand, heart transplant patients showed an increase (P 
<  0.03) in the specific activity of [3H ]NM N from arterial to 
coronary venous p lasm a (Fig. 2, lower panel). Control subjects 
showed a large decrease (P <  0*001) in the specific activity 
of [3H]NE from arterial to coronary venous plasma, whereas 
patients w ith  heart transplants show ed a m uch smaller ar­
terial-venous decrease (P <  0.05) in the specific activity of 
l/tH]NE across the heart (Fig. 2, upper panel).
The fractional extraction of PH ]N E was decreased by 8 '1 % 
in patients with heart transplants com pared to that in in­
nervated controls (0.70 ±  0.02 vs. 0.13 ± 0.2). Correction of 
out-flowing plasma concentrations of MNs for the contribu­
tion from metabolism of in-flowing catecholamines (see Eq 
IV in Materials and Methods) indicated no difference between
In contrast to the innervated hearts of normal volunteers fractional cardiac extractions of plasm a NM N (0,20 ±  0.05) 
and patients with angina, in which there were small, but and MN (0.21 ±  0.01) in patients w ith  heart transplants.
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Fig. 1. Plasma concentrations of NMN {upper panel) andMN {lower 
panel) in arterial and coronary venous plasma in control subjects {left) 
and patients who had received heart transplants 1 yr earlier Cright). 
Data represent individual paired values for arterial and coronary 
venous concentrations, with means shown by horizontal bat's.
Regional differences in specific activities of plasma
[3H]MNs
Fig, 2, Specific activities of [MH]NE {upperpanel) and [aH]NMN (low­
er panel) in arterial and coronary venous plasma in control subjects 
(left) and patients who had received heart transplants 1 yr earlier 
[right). Data represent individual paired values for arterial and cor­
onary venous specific activities, with means shown by horizontal bars.
sues, showed a large arterial-venous fall in the specific 
activity of plasma pHJMN (data not shown).
Changes in specific activities of [3H]NMN from in-flowing Regional extractions of catecholamines
to out-flowing plasma showed considerable variation among 
different tissues (Fig. 3), Like the heart, mesenteric organs 
showed an arterial-*venous decrease (P <  0.02) in die specific 
activity of [3H]NMN, whereas increases (P <  0.02) in 
[3H]NMN specific activity were observed across the kidneys 
and liver. There were no differences in specific activities of 
[3H]NMN in the in-flowing and out-flowing plasma of the 
forearm and lungs.
In contrast to the variable changes in specific activities of 
[3H]NMN from in-flowing to out-flowing plasma of different 
tissues, specific activities of [3H]MN showed consistent in­
creases (P < 0.02) from in-flowing to out-flowing plasma for 
the heart, forearm, lungs, mesenteric organs, liver, and kid­
neys (Fig. 3). The magnitude of the increase in specific ac­
tivity of [3H]MN was highly variable from organ to organ. 
The liver showed the largest increase, with a specific activity 
of [3H]MN in out-flowing plasma that was 97.3 ± 19.8% 
higher than that in in-flowing plasma. The lungs showed the 
smallest increase, with a specific activity of [3H]MN in out­
flowing plasma that was 9.0 ± 2,8% higher than that in 
in-flowing plasma. The adrenals, in contrast to all other tis-
Differences in magnitudes of increases in specific activities 
of [3H]MN from in-flowing to out-flowing plasma among the 
different organs and tissues (Fig. 3) showed a pattern similar 
to the differences in regional fractional extractions of [3H]E 
(Fig. 4). The lungs, with the lowest fractional extraction of 
[3H]E, also had the smallest increase in specific activity of 
[3H]MN from in-flowing to out-flowing plasma. The liver, 
with the highest fractional extraction of [3IT]E, also had the 
largest increase in [3H]MN specific activity from in-flowing 
to out-flowing plasma, in contrast, there was no relationship 
between fractional extractions of [3H]NE and differences in 
specific activities of [3H]NMN in in-flowing and out-flowing 
plasma.
Fractional extractions of [31~I]NE showed variable differ­
ences from those of [3H]E, depending on the tissue (Fig. 4), 
The fractional extraction of [3H]E was 35 ± 2% lower than 
that of [3H]NE in the heart, 10 ± 2% higher than that of 
[3H]NE in the forearm, 10 ± 4% higher than that of [3H]NE 
in the kidneys, not different in mesenteric organs, and 4 ± 1 % 
lower than that of [3H]NE in the liver.
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F ig. 3. Percent differences in specific activities of [‘''H’INMN and
from in-flowing to out-flowing plasma across the heart, fore­
arm, and lungs (upper panel) and across the kidneys, mesenteric 
organs, and liver (lowerpanel), Values represent the mean :t sum. i!', 
An increase (P < 0.05) in specific activity from in-flowing to out­
flowing plasma. 1\ A decrease (P < 0.05) in specific activity from 
in-flowing to out-flowing plasma.
Regional extractions of M N
Fractional extractions of MN by the various organs and 
tissues were lower than those of the catecholamines, but, in 
general, showed similar variation among organs as the pre­
cursor amines (Table 2). The highest fractional extraction of 
MN was in the liver; the lowest was in the lungs.
Regional removals and spillovers of catecholamines
Rates of NE spillover and removal showed wide variation 
among different tissues and organs (Table 3). As expected, 
the adrenals showed the largest spillover of E, amounting to 
91 % of the summed total (Table 4). The highest spillover rates 
of NE were observed for the kidneys and mesenteric organs, 
whereas the liver m ade the largest contribution to the re­
moval of circulating NE and E. Although there were large 
differences between NE spillover and removal rates among
ßo
idocl
«h
so
is
$
Kidneys Mesenteric
organs
Liver
Fro. 4. Fractional extractions of NE and E by the heart, forearm, and 
lungs (upper panel) and by the kidneys, mesenteric organs, and liver 
(lower panel). Values represent the mean ± hkm. !|:, Lower (P < 0.05) 
fractional extractions of E than NE. I, Higher (P < 0.05) fractional 
extractions of E than NE,
individual tissues, the sum  of NE spillover rates for all tissues 
was similar to the sum  of removal rates.
Regional metabolism o f catecholamines to M Ns
Only small proportions ( < 6%) of the E or NE extracted 
from the plasma entering the various organs and tissues 
appeared in the plasm a effluent as M N or N M N  (Tables 3 and 
4). Conversion of extracted catecholamines to MNs varied 
widely among tissues and  organs; it was highest in the liver 
and lowest in the heart. Between 30-200% m ore MN a p ­
peared in out-flowing plasm a from extracted E than NM N 
from extracted NE.
Much more N M N  w as derived from the metabolism of 
locally released than circulating NE for all tissues, apart from 
the liver (Table 3). The liver, p roducing  60% of its N M N  from 
extracted NE, also m ade the largest single contribution (54%) 
to the NM N derived from m etabolism  of circulating NE,
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TABLE 2. Rei
metanephrines
Fractional 
extraction (%): Removal rates (pmol/min)
MN NMN MN
Heart
Skeletal muscle
Lungs
Kidneys
Mesenteric organs 
Liver
19.9 ±  1.2 
39.1 ± 1.9 
7,2 ± 1.5
40.4 ± 1.5
30.5 ± 4,0
68.5 ± 4.2
5.8 ± 0,7
40.1 ± 8.5
71.2 ± 19.7 
60,6 ± 4.4 
61.5 ± 13.9
184.2 ± 33.4
5.1 ± 0.5 
46.8 ± 8.5 
52,0 ± 12,4 
50.4- ± 4.5 
44.5 ± 12,2 
118.6 ± 23.7
Total 423 317
Results represent the mean ± s e m ,  Fractional extractions of MN 
were estimated from decreases in inflowing and outflowing plasma 
MN concentrations (see Table 1) after correction of the outflowing 
concentration for the contribution of local metabolism of extracted È 
(see Eq IV in Materials and Methods), Removal rates wet'e estimated 
from the product of the fractional extinction of MN, the inflowing 
plasma concentration of MN or NMN, and the plasma flow through 
the organ.
However, only 19% of the N M N  produced by all tissues was 
derived from metabolism of NE after entry into the circula­
tion; most (81%) was derived from metabolism of locally 
released NE before entry into the circulation. Regional sp­
illovers of N M N  derived from locally released NE were 
typically a small fraction (3-13%) of NE spillovers; the ex­
ception to this was the adrenals, w here NM N spillover was 
33% that of NE spillover. The adrenals also m ade the single 
largest contribution (23%) to the spillover of NM N from all 
tissues.
The pattern of total and regional spillovers of MN derived 
from locally released and rem oved E (Table 4) showed some 
similarities to the pattern for N M N  (Table 3), but also many 
differences. Similar to the situation for NMN, the adrenals 
made the largest single contribution to the combined spill­
overs of M N from all organs and  tissues; however, the extent 
of this contribution (91%) w as m uch larger than that for
NM N (23%).
Some spillover of E was detected from m ost organs and 
tissues, although far less than from the adrenals. Thus, like 
NMN, some spillover of MN from these extraadrenal tissues 
was derived from metabolism of locally released E (Table 4). 
However, unlike the situation for NM N, all extra ad renal 
tissues produced more MN from E rem oved from the cir­
culation than from locally released E. Similar to the situation 
for NE and NM N, the liver m ade the single largest contri­
bution to removal of circulating E and produced the most 
M N from circulating E. However, metabolism of E after its 
release into the circulation m ade only a minor (6%) contri­
bution to total M N  production, and only a small am ount (3%) 
of MN was produced locally from E released by  extraadrenal 
tissues. Most M N (91%) was formed by local metabolism of 
E produced within the adrenals.
D iscu ssion
In addition to providing an examination of regional release 
and removal of NE and E, this s tudy  shows how the cat­
echolamines are metabolized to M Ns after their local release 
within tissues or removal from the circulation. There are
considerable differences in the production of MNs among 
various tissues. The adrenals in particular are an important 
source of MNs, providing an explanation for the extraordi­
nary sensitivity of these metabolites for the diagnosis of 
pheochromocytoma.
The lower concentrations of NM N in hepatic and right 
renal venous plasma than in arterial plasma agree with pre­
vious findings (16), This and the extractioi^i of MN by all 
extraadrenal tissues indicate that assessment of regional pro­
duction of MNs, like catecholamines, requires consideration 
of their local removal. For catecholamines, this is achieved by 
analysis of arterial-venous decreases in the specific activity 
of iv infused 3H-labeled catecholamines (11). The pro­
nounced decrease in the specific activity of [3H.]NE from 
arterial to coronary venous plasma in control subjects and the 
negligible decrease in heart transplant patients, who have 
little cardiac NE release (17), illustrate how arterial-venous 
decreases in the specific activity of plasma [3H]NE reflect 
local release of endogenous NE,
Differences in specific activities of [3H]NMN are more 
complex to interpret than those in l3H]NE, The decrease in 
specific activity of [3H]NE from in-flowing to out-flowing 
plasma is dependent only on local release of unlabeled NE, 
whereas any change in that of [3H]NMN is dependent on 
both metabolism of locally released NE and pITJNE removed 
from in-flowing plasma. Reversal of the normally observed 
arterial-coronary venous increase in plasma NM N to a de­
crease in heart transplant patients reflects the lack of cardiac 
NE release in these subjects; the resulting single source of 
NMN from in-flowing plasma NE together with the much 
higher specific activity of plasma [3H]NE than of [31-I]NMN 
results in an increase in the specific activity of [3H]NMN from 
arterial to coronary venous plasma. In the innervated heart, 
additional production of NMN from locally released unla­
beled NE results in an overall arterial-venous decrease in 
pH]NM N specific activity,
Increases in specific activity of plasma [3H]MN across all 
tissues, except the adrenals, reflect a similar situation to the 
transplanted heart, where specific activity differences de­
pend on the extraction, but not the local release, of cat­
echolamines. The variable regional differences in specific 
activity of [3H]NMN reflect differences in the amounts of 
NMN derived from locally released or extracted NE. The 
liver, with the largest removal and smallest spillover of NE, 
also had the largest in-flowing to out-flowing increase in the 
specific activity of plasma PlTlNMN.
In all tissues, except the adrenals, regional spillovers of 
NM N were determined using the fractional extractions of 
MN, which were assumed to equal those of NMN. Fractional 
extractions of MN were determined after correction of the 
am ount of locally extracted E converted to MN; it was as­
sumed that the amount of locally released E converted to MN 
was negligible. Both assumptions deserve comment. Similar 
total body clearances of NM N and MN and equal contribu­
tions of deamination to plasma clearances of both metabo­
lites (7) support the assumption of equivalent fractional ex­
tractions of MN and NMN. Further support is provided here 
by the similar fractional extractions of MN and NM N in 
transplanted hearts. The small, bu t detectable, spillover of E 
from extraadrenal tissues is in agreement with previous find­
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TABLE 3. Regional spillover and removal rates of NE and spillovers of NMN derived from NE released locally or removed from plasma
NE NMN spillover
Spillover Removal Released NE Removed NE Total
Heart 230 ± 31 142 ± 15 9.3 ± 0.9 1,1 ± 0.2 10.4 ± 1.0
Skeletal muscle 435 ± 78 312 ± 62 52.4 ± 16.3 4,0 ± 1.4 56.4 ± 16.6
Lungs 253 ± 114 328 ± 109 53.6 ± 25.6 14.5 ± 8.6 68.1 ± 30.7
Kidneys 976 ± 77 629 ± 45 33.5 ± 4.3 11.4 ± 1.2 44.9 ± 4.5
Mesenteric organs 1571 ± 392 347 ± 74 48.4 ± 12.6 4,1 ± 0.8 52.5 ± 10.3
Liver 214 ± 63 2374 ± 589 27.1 ± 11.7 40.8 ± 11.4 67.9 ± 8.0
Adrenals 274 ± 51 20 ± 1 91.3 ±  35.9 <20 91.3 ± 35.9
Total 3953 4152 316 76 392
Values represent the mean ± sem  rates (picomoles per min). Spillover rates of NE and total spillover rates of NMN were estimated according 
to Eq V in Materials and Methods. Removal rates of NE were estimated from the product of its fractional extraction, inflowing plasma 
concentration, and the plasma flow through the tissue. The spillover of NMN derived from local removal of plasma NE was estimated according 
to Eq VII in Materials and Methods. Subtraction of the latter estimate from the total spillover of NMN provided an estimate of the spillover 
of NMN derived from locally released NE. For the adrenals, estimates were derived without correction for the negligible influence of local 
extraction.
TABLE 4. Regional spillover and removal rates of E and spillovers of MN derived from E released locally or removed from plasma
E MN spillover
Spillover Removal Released E Removed E Total
Heart 7 ± 1 24 ± 3 0.2 ± 0.1 0.5 ± 0.1 0.7 ± 0.1
Skeletal muscle 2 ± 1 133 ± 51 0.5 ± 0.3 2.8 ± 1.2 3.3 ± 1.3
Lungs <1 46 ± 39 <0.5 7.7 ± 1.8 7.7 ± 1.8
Kidneys 23 ± 5 166 ± 22 1.7 ± 0.4 4.1 ± 0.4 5.8 ± 0.5
Mesenteric organs 33 ± 19 79 ± 20 3.4 ±  1.9 3.5 ± 0.7 6.9 ± 1.7
Liver 31 ± 18 216 ± 50 10.1 ± 5.6 10.9 ± 2.2 21.0 ± 3.7
Adrenals 979 ± 175 4 ± 1 448.8 ± 193 < 4 448.8 ± 193
Total 1075 668 465 29 494
Values represent the mean ± SEM rates (picomoles per min). Spillover and removal rates of E and spillover rates of MN derived from local removal 
of plasma E wore estimated as described in Table 3 for NE and NMN. The spillover of MN derived from locally released E was estimated from the 
product of the E spillover with the ratio of NMN spillover to NE spillover and the ratio of extracted E converted to MN to extracted NE converted 
to NMN. Total spillovers of MN were then estimated from the sum of MN spillovers derived from locally released and removed E,
ings (2,18) and suggests that some MN may be formed from 
locally released E. However, MN production from locally 
released E was less than that from extracted E, and the latter 
source influenced regional differences in plasma MN by only 
2-10%. Therefore, the second assumption introduces negli­
gible error into estimates of MN extraction (<3% underes­
timation) for most tissues. In the liver, fractional extractions 
of MN may have been underestimated by up to 8%.
Larger regional production of MNs from extracted E than 
NE is in agreement with findings in rats (7,19) and humans 
(20), in which infusions of E and NE produced larger in­
creases in plasma MN than NMN, This is consistent with 
more efficient removal of E than NE by extraneuronal uptake 
and less efficient removal by neuronal uptake (2, 21, 22). NE 
is also a better substrate than E for monoamine oxidase (23). 
All of these differences contribute to greater availability of E 
than of NE for catechol-O-methyltransferase.
Larger fractions of NMN derived from locally released 
than circulating NE are consistent with findings in rats (19) 
and humans (20) that more NMN is produced from NE 
before than after its release into plasma. In humans, 16% of 
plasma NM N is derived from NE after its release into plasma 
(20), a result close to the 19% contribution indicated here by 
the sum of regional NM N spillovers. In the liver, however, 
60% of NM N is derived from plasma NE, reflecting the 
importance of this organ for the removal of circulating 
catecholamines.
Although m ost N M N  derived from circulating NE is 
formed, in the liver, the most im portant single source of NM N 
is the adrenals. There is some previous evidence for an a d ­
renal source of NMN; catechol-O-methyltransferase is 
present in adrenal tissue (24), plasma N M N  concentrations 
are lower in adrenalectomized patients than in control sub­
jects (20), and plasm a N M N  concentrations are higher in the 
common vein draining the left kidney and the left adrenal 
gland than the vein draining the right kidney ('16). The 
present study extends these findings by show ing 10-fold 
higher N M N  concentrations in adrenal venous than arterial 
plasma and a 23% contribution of the adrenals to circulating
NMN.
In humans, only 10% of the M N  in plasm a is derived from 
circulating E, suggesting that the other 90% is formed from 
O-methylation of E in the adrenals (20), This conclusion is 
supported here by the 87-fold increase in plasma concentra­
tions of MN from arterial to adrenal venous plasma, which 
translates into a 91% contribution of the adrenals to the 
spillover of MN from all tissues.
The finding that the adrenals are a major source of circu­
lating M Ns has im portan t implications for the use of these 
metabolites in the diagnosis of pheochromocytoma. The su ­
periority of 24-h urinary  excretion rates of MNs over other 
catecholamine metabolites for the diagnosis of pheochrom o­
cytoma (25, 26) is explained not only by  preferential m etab­
olism of circulating catecholamines by extraneuronal pa th ­
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ways (10), but also by the primary source of MNs from 
chromaffin tissue.
Other findings suggest that measurements of MNs in 
plasma provide a useful test for the presence of a pheochro­
mocytoma (8, 27, 28). Our own observations establish that 
measurements of plasma MNs offer a superior method for 
diagnosis of the tumor than measurements of plasma cat­
echolamines (29). Even when quiescent and not releasing 
catecholamines, pheochromocytomas appear to actively me­
tabolize catecholamines to the O-methylated derivatives, re­
gardless of their adrenal or extraadrenal location.
MNs are produced extraneuronally, whereas cat­
echolamines are removed by neuronal and extraneuronal 
uptake (30). Differences in the relative importance of neu­
ronal and extraneuronal uptake explain the small and highly 
variable amounts of NMN or MN produced by extraadrenal 
tissues relative to the amounts of NE or E removed from 
plasma. The heart, which removes NE largely by neuronal 
uptake (6), also produces the smallest fraction (0.77%) of 
NMN from extracted NE, In this study, the innervated heart 
removed 70% of the [3H]NE entering the coronary circula­
tion, whereas in cardiac transplant patients, only 13% was 
removed, presumably by extraneuronal uptake. If it is as­
sumed that the ratio of extraneuronal uptake to coronary 
venous outflow of [3H]NE is the same in transplanted and 
innervated hearts, then only 4.5% (13/87 of 30%) of in-flow­
ing NE and 6.4% (4.5% of 70%) of extracted NE is removed 
by extraneuronal uptake in innervated hearts. Thus, 12% 
(0.77% of 6.4%) of the NE removed by extraneuronal uptake 
appears in coronary venous plasma as NMN. Assuming a 
similar proportion for locally released NE indicates, from the 
total cardiac spillover of NMN (10.4 pmol/min), that extra­
neuronal uptake of NE is 87 pmol/min (10.4/0.12). Cardiac 
NE spillover is about 3 times this rate, and neuronal uptake 
is 10-fold that of NE spillover (5). Thus, extraneuronal up take 
removes a small portion (<4%) of the NE released by cardiac 
sympathetic nerves. This is less than the 10% estimated for 
the whole body (6)/ consistent with the greater importance of 
neuronal over extraneuronal uptake for removal of cat­
echolamines in the heart than in other tissues (21).
Although this study provides a comprehensive examina­
tion of regional spillover and removal rates of MNs and 
catecholamines, it should be recognized that the data were 
obtained from a variety of patient groups studied under 
different conditions. Thus, some caution must be exercised 
in extrapolating the present comparisons among tissues to 
normal regional variations in sympathetic out-flow and cat­
echolamine metabolism. The present data, however, do in­
dicate wide regional variability in the extraneuronal pro­
duction of MNs from catecholamines released locally or 
removed from the circulation. The substantial contribution of 
the adrenals to production of MNs explains the extraordi­
nary sensitivity of these metabolites for the diagnosis of 
pheochromocytoma.
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